Morepen Laboratories Q1 Results
- BSE: 500288
- NSE: MOREPENLAB
- ISIN: INE083A01026
- Sector: Biotechnology & Drugs
BSE
80.12
0.64 (0.81%)
0.64 (0.81%)Volume1.68 M
Updated: Fri 7 Aug, 2026 | 15:54:59
NSE
80.250.83 (1.05%)
0.83 (1.05%)Volume36.46 M
Updated: Fri 7 Aug, 2026 | 15:50:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Incomeâ‚ą570.13 Cr.(34.07%)
- Operating Profitâ‚ą74.19 Cr.(389.81%)
- Profit After Taxâ‚ą56.40 Cr.(424.73%)
- Operating Margin13.01%(265.33%)
Note: Comparison is on YoY basis
Quarterly - Morepen Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 495.94 | 466.02 | 6.42% | 409.32 | 20.93% |
| Depreciation/ Amortization | 8.35 | 5.75 | 45.27% | 5.73 | -7.49% |
| Operating Income | 74.19 | 18.70 | 296.70% | 45.89 | 389.81% |
| Net Income | 56.40 | 15.74 | 258.21% | 36.17 | 424.73% |
| Other Operating Expenses Total | 34.68 | 48.65 | -28.72% | 28.54 | -4.53% |
| Net Income Before Taxes | 74.53 | 23.29 | 220.03% | 48.17 | 380.31% |
| Total Revenue | 570.13 | 484.72 | 17.62% | 455.22 | 34.07% |
| Selling/ General/ Admin Expenses Total | 121.40 | 99.90 | 21.52% | 82.98 | 32.22% |
| Diluted Normalized EPS | 1.03 | 0.28 | 267.86% | 0.71 | 415.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.